ZORETIC RICHARD C 4

What Happened

• Richard C. Zoretic, a director of Molina Healthcare, received a grant of 237 shares of common stock on July 1, 2026. The shares were valued at the closing price of $232.55 per share, for an aggregate grant value of $55,114. This was an award (grant) under the Issuer’s 2025 Equity Incentive Plan rather than an open-market purchase or sale.

Key Details

• Transaction date: July 1, 2026 (Form 4 filed July 2, 2026 — filed the next day, i.e., timely).
• Shares granted: 237 shares at $232.55 per share; total value reported $55,114.
• Plan: Grant made under the Issuer’s 2025 Equity Incentive Plan as the quarterly portion of the director equity program.
• Award mechanics: Annual director equity award set at $220,000 with one-quarter (~$55,000) awarded each quarter; the July 1, 2026 closing price yielded 237 shares.
• Holding: All shares are held by the Richard Charles Zoretic Revocable Living Trust (per footnote).
• Filing timeliness: Reported on July 2, 2026 for the July 1 transaction (appears timely).

Context

• This is a routine director compensation grant, not a market purchase or sale by the insider. Director equity awards are commonly used to compensate and align directors with shareholders; they do not necessarily signal a personal buy or sell decision.